Avatrombopag maleate, a novel thrombopoietin receptor agonist, has emerged as a potential therapeutic agent for the treatment of various myeloid disorders. Its mechanism of action involves stimulating platelet https://deaconxlpl399320.wikicorrespondence.com/user